Skip to content

US Physical Therapy USPH Stock-Based Comp

Stock-Based Comp at other companies

Select Medical Holdings logo
Select Medical HoldingsSEM
$4.64M+19.2%
Encompass Health Corporation logo
Encompass Health CorporationEHC
$11.5M+21.1%
Talkspace, Inc. logo
Talkspace, Inc.TALK
$2.96M+26.8%
LifeStance Health Group logo
LifeStance Health GroupLFST
$15.2M-18.2%
Tenet Healthcare logo
Tenet HealthcareTHC
$25M+19.0%
Concentra Group Holdings Parent logo
Concentra Group Holdings ParentCON
$4.14M+82.2%

Other financials

Income statement

See full
Revenue$198.3M+7.9%
Gross profit$32.8M+5.4%
Operating income$12.5M-36.5%
Net income$5.0M-49.1%
EPS (diluted)-$0.12-115%

Balance sheet

See full
Cash & equivalents$28.4M-27.4%
Total debt$169.4M+12.6%
Total equity$469.0M-5.7%
Total assets$1.2B+5.3%

Cash flow

See full
Operating cash flow$3.8M+181%
CapEx$5.4M+108%
Free cash flow-$1.6M+78.4%

Valuation

See full
Market cap$1.01B-10.7%
Enterprise value$1.15B-7.4%
P/E29×-4.9×
P/S1.3×-0.3×

Profitability

See full
Gross margin19%+0.9pp
Operating margin10%+0.3pp
Net margin4.4%-0.4pp
FCF margin8.4%+0.4pp

Returns & leverage

See full
Return on equity7.2%+0.4pp
Debt / equity0.4×+0.1×
Current ratio1.2×0.0×

Where this comes from

Reported directly by US Physical Therapy in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: US Physical Therapy’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about US Physical Therapy's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is US Physical Therapy's stock-based comp?
US Physical Therapy (USPH) reported stock-based comp of $2.31M in Q1 2026.
How has US Physical Therapy's stock-based comp changed year-over-year?
US Physical Therapy's stock-based comp increased by 30.4% year-over-year, from $1.77M to $2.31M.
What is the long-term trend for US Physical Therapy's stock-based comp?
Over 4 years (2021 to 2025), US Physical Therapy's stock-based comp has grown at a 1.3% compound annual growth rate (CAGR), from $7.87M to $8.27M.
What does stock-based comp mean?
Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.